Ftse Mib
33.922,16
0,12%
DAX
17.737,36
-0,64%
S&P 500
4.967,23
-0,88%
NASDAQ Composite
15.282,01
-2,05%
Bitcoin
63.957,50
0,21%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni Regno Unito LSE Addex Therapeutics Ltd (0QNV) Addex Therapeutics Ltd (0QNV) Notizie

Addex Therapeutics Ltd

0QNV
3,02
0,00 (0,00%)
19 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: CHF

Ultime notizie

Data Ora Fonte Titolo
19/4/202407:00UKREGAddex to Present at the Swiss Biotech Day 2024
18/4/202407:00UKREGAddex Therapeutics Reports Full Year 2023 Financial Results..
11/4/202407:00UKREGAddex Therapeutics to Release Full-Year 2023 Financial..
03/4/202407:00UKREGAddex and Perceptive Launch Neurosterix with $63 Million to..
14/3/202407:00UKREGAddex to Present at the Bio-Europe Spring 2024 Conference
31/1/202407:00UKREGAddex Enters into At-The-Market ADS Offering Agreement with..
09/1/202407:00GLOBEAddex to Present at the Swiss Equities Baader Conference
05/1/202407:30GLOBEAddex to Present at Biotech Showcase™ 2024
20/12/202307:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
14/12/202307:00GLOBEAddex Creates Treasury Shares
29/11/202307:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
28/11/202307:00GLOBEAddex Convenes Extraordinary General Meeting
23/11/202307:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
14/11/202307:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
08/11/202307:00GLOBEAddex Regains Nasdaq Listing Compliance
02/11/202307:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
20/10/202307:00GLOBEAddex Completes ADS Ratio Change
06/10/202322:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
20/9/202307:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
06/9/202307:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
05/9/202307:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
04/9/202307:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
10/8/202307:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
04/8/202307:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
03/8/202307:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
24/7/202307:00GLOBEAddex mGlu2PAM Demonstrates Potential in Substance Use..
15/6/202307:00GLOBEAddex Increases Issued Share Capital to Create Treasury..
01/6/202307:00GLOBEAddex Shareholders Approve All Resolutions at Annual General..
18/5/202307:00GLOBEAddex Receives Nasdaq Notification Regarding Minimum Bid..
11/5/202307:00GLOBEAddex Reports Q1 2023 Financial Results and Provides..
10/5/202307:00GLOBEAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s..
05/5/202307:00GLOBEAddex Convenes Annual General Meeting 2023
04/5/202307:00GLOBEAddex Therapeutics to Release Q1 2023 Financial Results and..
Apertura: Min: Max:
Chiusura: 3,02

La tua Cronologia

LSE
0QNV
Addex Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network